Related Experiment Videos
The carbohydrate moiety of human glycophorin in CDG syndrome
B Krotkiewska1, K Zwierz, H Krotkiewski
1Department of Biochemistry, University Medical School, Wroclaw, Poland.
Insights
Congenital disorders of glycosylation (CDG) affect erythrocyte membrane proteins. This study found altered carbohydrate content and glycosylation patterns in glycophorin from CDG patients, impacting both N- and O-glycans.
Area of Science:
- Biochemistry
- Molecular Biology
- Human Genetics
Background:
- Human glycophorin is a key sialoglycoprotein in erythrocyte membranes.
- Glycosylation is crucial for protein structure and function.
- Congenital disorders of glycosylation (CDG) are a group of inherited metabolic diseases affecting protein glycosylation.
Purpose of the Study:
- To investigate glycosylation differences in human glycophorin between healthy individuals and CDG patients.
- To characterize the impact of CDG syndrome on glycophorin's N- and O-glycans.
Main Methods:
- Isolation of glycophorin from erythrocytes of healthy individuals and CDG patients.
- Sugar analysis to quantify carbohydrate content.
- Enzyme-Linked Immunosorbent Assay (ELISA) using biotinylated lectins to assess N- and O-glycan structures.
Main Results:
- Three out of four CDG-glycophorin samples showed reduced carbohydrate content compared to healthy controls.
- Lectin-binding assays indicated significant alterations in both N- and O-glycan structures of glycophorin in CDG patients.
- These findings suggest a broad impact of CDG syndrome on glycophorin glycosylation.
Conclusions:
- Congenital disorders of glycosylation significantly affect the glycosylation of human erythrocyte glycophorin.
- Both N-linked and O-linked glycans of glycophorin are demonstrably altered in CDG syndrome.
- Further research is warranted to understand the functional consequences of these glycosylation defects.
Abstract:
Human glycophorin, the major sialoglycoprotein of erythrocyte membranes, was isolated from erythrocytes of healthy individuals and four patients with CDG syndrome. Sugar analysis revealed lower carbohydrate content in three out of four CDG-glycophorin samples. In order to characterize closer the glycosylation differences between glycophorin samples in health and disease, reaction with four biotinylated lectins was performed, using ELISA procedure on polystyrene microplates. Results obtained so far strongly suggest that both N- and O-glycans of glycophorin are affected in CDG syndrome.